n.boateng
TL2 Moderator · Angers
Contributes reviews on supplier material. Based in Angers.
Joined 14 December 2024 · last posted 6d
79 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #85 · Outcomes › Progress reports · 22 Jul 2026 · 12 likes Coming back to post #83, because the follow-up matters more than the original answer. Medication changes: escalating dose, or adding or removing other medications, can…
-
Spreadsheets: an appreciation — what changed since Replied, post #99 · Lounge › Off topic · 13 Jul 2026 · 1 like Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
How to ask a question when you cannot say why you are asking it Replied, post #35 · Start Here › How to Ask · 9 Jul 2026 · 1 like Coming back to post #33, because the follow-up matters more than the original answer. Asking a follow-up: new topic or reply in the old one? If the answer depends on…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #58 · Evidence › Journal club · 5 Jul 2026 · 0 likes Picking up post #55: that is the part I would want checked first. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg…
-
Pages past their review date, listed — does this still hold? Replied, post #29 · Meta › Wiki maintenance · 28 Jun 2026 · 3 likes post #28 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #11 · Start Here › How to Ask · 28 Jun 2026 · 14 likes Coming back to post #9, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #39 · Evidence › Journal club · 16 Jun 2026 · 12 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #103 · Practice › Reconstitution · 12 Jun 2026 · 4 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Revisiting: The best-written scientific paper you have read Replied, post #24 · Lounge › Off topic · 10 Jun 2026 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #42 · Practice › Storage & stability · 1 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What published stability data actually covers, and what it does not Replied, post #3 · Practice › Storage & stability · 23 May 2026 · 12 likes post #2 answers the question as asked. The question underneath it is different. Published stability data applies specifically to the formulation studied, under the…
-
Reading a trial's population section before its results Replied, post #25 · Evidence › Trials · 16 May 2026 · 7 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #118 · Practice › Reconstitution · 30 Apr 2026 · 10 likes This follows post #115 rather than contradicting it. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #8 · Analytics › Mass spectrometry · 29 Apr 2026 · 10 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #6 · Practice › Storage & stability · 26 Apr 2026 · 22 likes On post #2 — agreed on the reasoning, with one qualification. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #16 · Practice › Reconstitution · 18 Apr 2026 · 1 like Worth separating two things that post #12 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe…
-
List price versus negotiated price versus what you pay Replied, post #113 · Access › Pricing · 17 Apr 2026 · 1 like Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
List price versus negotiated price versus what you pay Replied, post #95 · Access › Pricing · 16 Apr 2026 · 3 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #61 · Start Here › Welcome · 3 Apr 2026 · 12 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #7 · Practice › Dosing & titration · 14 Mar 2026 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #37 · Lounge › Introductions · 11 Mar 2026 · 0 likes Coming back to post #35, because the follow-up matters more than the original answer. No spam: introductions are not a place to advertise commercial products or…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #19 · Compounds › Repair & healing peptides · 8 Mar 2026 · 20 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #61 · Data & Tools › Calculators · 2 Mar 2026 · 0 likes post #60 answers the question as asked. The question underneath it is different. Units: all calculators explicitly require units to be stated. This prevents the…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #8 · Access › Pricing · 28 Feb 2026 · 0 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #14 · Practice › Administration · 30 Jan 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Waist circumference technique and its repeatability Replied, post #38 · Outcomes › Progress reports · 13 Jan 2026 · 8 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #41 · Devices › Pens & autoinjectors · 9 Jan 2026 · 3 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
Aggregates and why a purity assay may miss them entirely Replied, post #51 · Analytics › Impurities & related substances · 5 Jan 2026 · 12 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Guidelines revision: what changed and why — one year on Replied, post #53 · Meta › Announcements · 1 Jan 2026 · 12 likes I read post #51 twice before replying, because I had assumed the opposite. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #50 · Sourcing › Vendor reports · 26 Dec 2025 · 3 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
Personal import allowances, compared Replied, post #9 · Access › International · 21 Dec 2025 · 3 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #7 · Practice › Reconstitution · 11 Dec 2025 · 0 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Absence of evidence and evidence of absence Replied, post #7 · Research Methods › Statistics · 29 Nov 2025 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Regression to the mean: if you select people with extreme values (very high or very…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #5 · Compounds › Oral incretins · 27 Oct 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Payment mechanics and the recovery options that do not exist Replied, post #70 · Sourcing › Payments · 22 Oct 2025 · 0 likes post #69 answers the question as asked. The question underneath it is different. Fraud and scams: if a supplier demands payment upfront with no recourse if delivery…
-
About the North America category Replied, post #5 · Regional › North America · 10 Oct 2025 · 3 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #45 · Practice › Storage & stability · 19 Sep 2025 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Request: show the solution author in the topic list Replied, post #3 · Meta › Feature requests · 14 Sep 2025 · 24 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #45 · Data & Tools › Datasets · 8 Sep 2025 · 17 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #13 · Start Here › How to Ask · 8 Sep 2025 · 0 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #13 · Evidence › Journal club · 4 Sep 2025 · 13 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #20 · Practice › Side effects · 27 Aug 2025 · 0 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #26 · Compounds › Oral incretins · 10 Aug 2025 · 7 likes This follows post #23 rather than contradicting it. Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no…
-
How to research a compound with no human data without deceiving yourself Replied, post #25 · Compounds › Other compounds · 31 Jul 2025 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #3 · Data & Tools › Calculators · 30 Jul 2025 · 10 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #13 · Compounds › Secretagogues & GH axis · 26 Jul 2025 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #136 · Compounds › Tirzepatide · 14 Jul 2025 · 2 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #43 · Sourcing › Regulatory · 6 Jul 2025 · 5 likes post #42 answers the question as asked. The question underneath it is different. Why this category is maintained as documentation, not as recommendations: the goal is…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #76 · Practice › Storage & stability · 1 Jul 2025 · 0 likes On post #72 — agreed on the reasoning, with one qualification. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #19 · Compounds › Secretagogues & GH axis · 27 Jun 2025 · 7 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #13 · Practice › Reconstitution · 18 Jun 2025 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #91 · Access › Insurance & coverage · 13 Jun 2025 · 2 likes Coming back to post #89, because the follow-up matters more than the original answer. Denial letters: the stated reason tells you exactly what to submit next. A denial…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #9 · Analytics › Method validation · 5 Jun 2025 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Publishing an inconvenient result: a case study Replied, post #28 · Sourcing › Independent verification · 2 Jun 2025 · 1 like Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #70 · Outcomes › Body composition · 20 May 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #65 · Compounds › Secretagogues & GH axis · 19 May 2025 · 0 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #9 · Clinical › Special populations · 15 May 2025 · 10 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #16 · Clinical › Bloodwork · 7 May 2025 · 2 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 1 May 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #38 · Data & Tools › Calculators · 28 Apr 2025 · 0 likes This follows post #35 rather than contradicting it. Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that…
-
Carryover and the ghost peak from last week's standard Replied, post #80 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Carryover and the ghost peak from last week's standard Replied, post #9 · Analytics › HPLC & UHPLC · 1 Apr 2025 · 4 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #94 · Access › International · 12 Mar 2025 · 19 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #2 · Wellbeing › Mental health · 1 Feb 2025 · 4 likes I read the opening post twice before replying, because I had assumed the opposite. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline…
-
Fixed versus detachable needles: the trade-offs Replied, post #120 · Devices › Syringes & needles · 18 Jan 2025 · 0 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #18 · Compounds › Oral incretins · 3 Jan 2025 · 26 likes I read post #16 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Isotonicity and what happens when you get it wrong Replied, post #11 · Pharmacology › Formulation chemistry · 28 Dec 2024 · 10 likes Amino acid residues and formulation: the specific sequence and composition of a peptide affects what formulation conditions it tolerates. Sequences high in methionine…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #8 · Compounds › Other compounds · 28 Dec 2024 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What we do not know about retatrutide, listed explicitly Replied, post #35 · Compounds › Retatrutide · 28 Dec 2024 · 19 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Body image changing more slowly than the body Replied, post #127 · Wellbeing › Mental health · 25 Dec 2024 · 5 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Revisiting: Moderation log format change Replied, post #63 · Meta › Announcements · 11 Dec 2024 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Criticising the method without criticising the authors Replied, post #22 · Evidence › Study critique · 6 Dec 2024 · 33 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #44 · Clinical › Prescriber conversations · 9 Nov 2024 · 4 likes Coming back to post #42, because the follow-up matters more than the original answer. Prescription logistics: confirm whether it will be filled locally, requires mail…
-
Time to steady state after a dose increase Replied, post #143 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 8 likes On post #139 — agreed on the reasoning, with one qualification. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #8 · Clinical › Comorbidities · 8 Oct 2024 · 3 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
How to ask for a dose change without antagonising anyone Replied, post #23 · Clinical › Prescriber conversations · 7 Sep 2024 · 28 likes Worth separating two things that post #19 runs together. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this…
-
Promotion criteria, and the one that stops most nominations Replied, post #50 · Documentation › Doc review · 31 Aug 2024 · 0 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #80 · Evidence › Journal club · 29 Jul 2024 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Assessing a warm arrival: the decision process — one year on Replied, post #105 · Sourcing › Logistics · 1 Jun 2024 · 21 likes post #104 answers the question as asked. The question underneath it is different. Import restrictions by jurisdiction: what is legal to import for personal use varies…